About Aerpio.

The company behind the science.

Kevin Peters - Chief Scientific Officer

Kevin PetersDr. Peters guided the development of AKB-9778 while at Akebia, and will continue to be in charge of scientific discovery and development for Aerpio. He was formerly the Group Medical Director, CV and Metabolic Disease in Global and Discovery Medicine at Bristol Myers Squibb and head of Therapeutic Angiogenesis research at Proctor & Gamble Pharmaceuticals. Prior to that Dr. Peters was an Associate Professor of Medicine and Pharmacology in the Division of Cardiology at Duke University Medical Center. Dr. Peters received his M.D. from the University of Iowa and was a Research Fellow at the University of California, San Francisco. Dr. Peters has published broadly in the areas of growth factor receptor signaling and vascular biology and has led several preclinical programs to clinical proof of concept in vascular and metabolic diseases.

LinkedIn Connect with Kevin